Apoptosis markers soluble Fas (sFas), Fas Ligand (FasL) and sFas/FasL ratio in patients with bacteremia: A prospective cohort study

Journal of Infection

Volumn 64, Issue 3, 2012, Pages 276-281

  Huttunen, Reetta ^a,b   Syrjänen, Jaana ^a,b   Vuento, Risto ^c   Laine, Janne ^a   Hurme, Mikko ^b,c   Aittoniemi, Janne ^c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^c PIRKANMAA HOSPITAL DISTRICT   (Finland)

Author keywords

Apoptosis; Bacteremia; Case fatality; Disease severity; Fas ligand; Outcome; Sepsis; SFas FasL; Soluble Fas

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; CREATININE; FAS ANTIGEN; FAS LIGAND;

ADULT; AGED; ANTIGEN DETECTION; APOPTOSIS; AREA UNDER THE CURVE; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; BETA HEMOLYTIC STREPTOCOCCUS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME IMMUNOASSAY; ESCHERICHIA COLI; FATALITY; FEMALE; HUMAN; HYPOTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPECIES COMPARISON; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; APOPTOSIS; BACTEREMIA; BIOLOGICAL MARKERS; COHORT STUDIES; FAS LIGAND PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; YOUNG ADULT;

EID: 84856598971     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.12.006     Document Type: Article

References (17)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
2. Hotchkiss R.S., Nicholson D.W. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006, 6:813-822.
3. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.
4. Turrel-Davin F., Guignant C., Lepape A., Mougin B., Monneret G., Venet F. Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients. Crit Care 2010, 14:R133.
5. Papathanassoglou E.D., Moynihan J.A., Ackerman M.H. Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? a review and a theoretical framework. Crit Care Med 2000, 28:537-549.
6. Paunel-Gorgulu A., Flohe S., Scholz M., Windolf J., Logters T. Increased serum soluble Fas after major trauma is associated with delayed neutrophil apoptosis and development of sepsis. Crit Care 2011, 15:R20.
7. Wheeler D.S. Death to sepsis: targeting apoptosis pathways in sepsis. Crit Care 2009, 13:1010.
8. Wang T.S., Deng J.C. Molecular and cellular aspects of sepsis-induced immunosuppression. J Mol Med 2008, 86:495-506.
9. Endo S., Inada K., Takakuwa T., Kasai T., Yamada Y., Wakabayashi G., et al. Nitrite/nitrate (NOx) and sFas antigen levels in patients with multiple organ failure. Res Commun Mol Pathol Pharmacol 1996, 92:253-256.
10. McCabe W.R. Gram-negative bacteremia. II. Clinical, laboratory, and therapeutic observations. Arch Intern Med 1962, 110:856-864.
11. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonca A., Bruining H., et al. The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
12. Boyd J.C. Mathematical tools for demonstrating the clinical usefulness of biochemical markers. Scand J Clin Lab Invest Suppl 1997, 227:46-63.
13. Huttunen R., Laine J., Lumio J., Vuento R., Syrjänen J. Obesity and smoking are factors associated with poor prognosis in patients with bacteraemia. BMC Infect Dis 2007, 7:13.
14. Jahr S., Hentze H., Englisch S., Hardt D., Fackelmayer F.O., Hesch R.D. Knippers R DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001, 61:1659-1665.
15. Matsuda N., Yamamoto S., Takano K., Kageyama S., Kurobe Y., Yoshihara Y., et al. Silencing of fas-associated death domain protects mice from septic lung inflammation and apoptosis. Am J Respir Crit Care Med 2009, 179:806-815.
16. Hotchkiss R.S., Swanson P.E., Freeman B.D., Tinsley K.W., Cobb J.P., Matuschak G.M., et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999, 27:1230-1251.
17. Zeerleder S., Zwart B., Wuillemin W.A., Aarden L.A., Groeneveld A.B., Caliezi C., et al. Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med 2003, 31:1947-1951.